Injective and Microsoft host agentic commerce event ahead of Token2049
In brief
- Injective and Microsoft host onchain agentic commerce event October 6 in Singapore, ahead of Token2049.
- Nova Program pairs Azure AI infrastructure with Injective agent tooling for developer projects.
- Injective Foundation offers up to $1 million venture capital for standout Nova Program projects.
- Platform features ERC-8004 onchain identity, efficient fee routing, and decentralized order book.
The Nova Program and Its Scope
Injective and Microsoft launched the Nova Program back in May 2026, a joint initiative designed to accelerate development at the intersection of AI and blockchain. The program targets developers building in this space, with a particular focus on Asia. Participants gain access to Azure AI services, Injective's tools, and grants exceeding $10,000. For projects that really stand out, the Injective Foundation is offering potential venture capital investments reaching up to $1 million.
The program was first unveiled at the Hong Kong Web3 Festival earlier in 2026. Now, as Token2049 approaches, the October 6 event in Singapore will give these projects a public stage.
Injective's Agentic Commerce Infrastructure
The event will spotlight Injective's growing suite of tools designed to let autonomous AI agents trade, transact, and interact on its blockchain without human intervention. This capability rests on several technical layers.
Injective's platform includes onchain identity capabilities through ERC-8004, a standard that gives AI agents verifiable identities on the blockchain. The platform also features efficient fee routing mechanisms designed for high-frequency agent trades, along with x402 micropayments for agent-to-agent commerce.
Injective's underlying architecture already supports a decentralized central limit order book for both spot and perpetual trading. This foundation has helped the platform scale: it's processed over $6.8 billion in volume related to real-world assets as of mid-2026.
Regulatory Footing and Market Context
Injective's positioning extends beyond pure technology. The platform became an SEC-registered transfer agent in 2026, a designation that allows it to maintain official records of securities ownership and handle transfers. This regulatory credential signals ambition to bridge blockchain infrastructure with traditional financial systems.
Token2049 Singapore runs October 7-8, with side events spanning October 5-11. Injective's October 6 event lands squarely in that window, positioning the Nova Program demos as a key lead-up to the conference's main programming.
